MediBIC Group (2369.T)
2369.T on Tokyo Stock Exchange
6,500JPY
22 Dec 2009
6,500JPY
22 Dec 2009
Price Change (% chg)
¥-220 (-3.27%)
¥-220 (-3.27%)
Prev Close
¥6,500
¥6,500
Open
--
--
Day's High
¥6,720
¥6,720
Day's Low
¥6,440
¥6,440
Volume
140
140
Avg. Vol
299
299
52-wk High
¥12,000
¥12,000
52-wk Low
¥5,620
¥5,620
About
MediBIC Group is a Japan-based company comprised of five business segments. The Biomarker Drug Discovery segment provides support solution services for new drug development, including the provision of analytical, clinical trial coordinate, data analytical and pharmacogenomics (PGx) test support services, as well as the sale of... (more)
No analyst recommendations are available for 2369.T.
Overall
| Beta: | 1.14 |
| Market Cap (Mil.): | ¥1,184.33 |
| Shares Outstanding (Mil.): | 0.18 |
| Annual Dividend: | -- |
| Yield (%): | -- |
Financials
| 2369.T | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 12.69 | 4.64 |
| EPS (TTM): | -- | -- | -- |
| ROI: | -- | 1.36 | 2.82 |
| ROE: | -- | 2.20 | 3.58 |
TABLE-MediBic Group <2369.T>-9-mth group results
9 months ended 9 months ended Year to
TABLE-MediBic Group <2369.T>-6mth group results
6 months ended 6 months ended Full year to Full year ended
MediBic Group <2369.T>-1qtr group results
3 months ended 3 months ended 6 months to Year to
Toshiba, Canon, others to team up on biochips
TOKYO (Reuters) - Toshiba Corp , Canon Inc and 30 to 40 other Japanese firms will team up to develop biochips, seeking new revenues in a market currently dominated by U.S. firms.





Earnings vs
Estimates